Identification of Biosignatures for Lurasidone (Latuda) Response in Bipolar Depression
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2017
Price : $35 *
At a glance
- Drugs Lurasidone (Primary)
- Indications Bipolar depression; Bipolar I disorders; Bipolar II disorders; Depression
- Focus Therapeutic Use
- 12 Oct 2017 Status changed from recruiting to completed.
- 23 Mar 2015 Planned End Date changed from 1 Dec 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.
- 23 Mar 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov record.